SC 13G: Rallybio Corp
Ticker: RLYB · Form: SC 13G · Filed: Jul 30, 2024 · CIK: 1739410
| Field | Detail |
|---|---|
| Company | Rallybio Corp (RLYB) |
| Form Type | SC 13G |
| Filed Date | Jul 30, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Rallybio Corp.
Risk Assessment
Risk Level: low
FAQ
What type of filing is this?
This is a SC 13G filing submitted by Rallybio Corp (ticker: RLYB) to the SEC on Jul 30, 2024.
What is the risk level of this SC 13G filing?
This filing has been assessed as low risk.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securiti).
How long is this filing?
Rallybio Corp's SC 13G filing is 3 pages with approximately 1,039 words. Estimated reading time is 4 minutes.
Where can I view the full SC 13G filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 1,039 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2024-07-30 21:06:36
Key Financial Figures
- $0.0001 — Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securiti
Filing Documents
- rallybiosch13gforjjdc.htm (SC 13G) — 46KB
- 0000904454-24-000439.txt ( ) — 48KB
(a)
ITEM 1(a) NAME OF ISSUER: Rallybio Corporation
(b)
ITEM 1(b) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES: 234 Church Street, Suite 1020 New Haven, CT 06510
(a)
ITEM 2(a) NAME OF PERSON FILING: This statement is being filed by Johnson & Johnson, a New Jersey corporation (“J&J”), and Johnson & Johnson Innovation-JJDC, Inc., a Delaware corporation (“JJDC”). JJDC is a wholly-owned subsidiary of J&J. The securities reported herein as being held by J&J and JJDC are directly beneficially owned by JJDC. J&J may be deemed to indirectly beneficially own the securities that are directly beneficially owned by JJDC. The Joint Filing Agreement between J&J and JJDC is attached hereto as Exhibit A.
(b)
ITEM 2(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE: J&J: One Johnson & Johnson Plaza, New Brunswick, NJ 08933 JJDC: 410 George Street, New Brunswick, NJ 08901
(c)
ITEM 2(c) CITIZENSHIP: J&J: New Jersey JJDC: Delaware
(d)
ITEM 2(d) TITLE OF CLASS OF SECURITIES: Common Stock, $0.0001 par value (“Common Stock”)
(e)
ITEM 2(e) CUSIP NUMBER: 72120L100 ITEM 3 Not applicable. ITEM 4 The information set forth in the cover pages of this Schedule 13G is incorporated herein by reference. Percentage ownership as of April 10, 2024 is based on 41,448,333 shares of Common Stock outstanding, consisting of (i) 37,811,970 shares outstanding as of March 31, 2024, as reported in the Issuer’s proxy in a private placement on April 10, 2024. Percentage ownership as of the date of this filing is based on 41,449,297 shares of Common Stock outstanding as of May 6, 2024, as reported in the Issuer’s Report on Form 10-Q for the period ended March 31, 2024 filed with the Securities and Exchange Commission on May 9, 2024. ITEM 5 Not applicable. ITEM 6 Not applicable. ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT COMPANY: Not applicable. ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: Not applicable. ITEM 9 NOTICE OF DISSOLUTION OF GROUP: Not applicable. ITEM 10 CERTIFICATION: By signing below the undersigned certify that, to the best of their knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of their knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. Dated: July